MV Capital Management’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.46K | Buy |
17
+3
| +21% | +$263 | ﹤0.01% | 840 |
|
|
2026
Q1 | $1.27K | Buy |
14
+2
| +17% | +$184 | ﹤0.01% | 822 |
|
|
2025
Q4 | $1.08K | Hold |
12
| – | – | ﹤0.01% | 806 |
|
|
2025
Q3 | $1.18K | Sell |
12
-13
| -52% | -$1.29K | ﹤0.01% | 775 |
|
|
2025
Q2 | $2.28K | Sell |
25
-37
| -60% | -$3.58K | ﹤0.01% | 691 |
|
|
2025
Q1 | $7.02K | Buy |
62
+3
| +5% | +$321 | ﹤0.01% | 570 |
|
|
2024
Q4 | $6.23K | Sell |
59
-75
| -56% | -$8.05K | ﹤0.01% | 580 |
|
|
2024
Q3 | $14.5K | Sell |
134
-22
| -14% | -$2.4K | ﹤0.01% | 479 |
|
|
2024
Q2 | $16.9K | Sell |
156
-14
| -8% | -$1.65K | ﹤0.01% | 448 |
|
|
2024
Q1 | $22.4K | Buy |
170
+2
| +1% | +$250 | ﹤0.01% | 404 |
|
|
2023
Q4 | $20.4K | Buy |
168
+7
| +4% | +$781 | ﹤0.01% | 415 |
|
|
2023
Q3 | $18.1K | Buy |
161
+20
| +14% | +$2.54K | ﹤0.01% | 408 |
|
|
2023
Q2 | $20.5K | Buy |
141
+2
| +1% | +$272 | ﹤0.01% | 400 |
|
|
2023
Q1 | $18K | Buy |
139
+8
| +6% | +$1K | ﹤0.01% | 422 |
|
|
2022
Q4 | $16.7K | Buy |
131
+14
| +12% | +$1.63K | ﹤0.01% | 378 |
|
|
2022
Q3 | $12K | Sell |
117
-15
| -11% | -$1.65K | ﹤0.01% | 428 |
|
|
2022
Q2 | $14K | Buy |
132
+38
| +40% | +$4.51K | ﹤0.01% | 374 |
|
|
2022
Q1 | $12K | Buy |
94
+24
| +34% | +$2.89K | ﹤0.01% | 432 |
|
|
2021
Q4 | $9K | Buy |
70
+43
| +159% | +$5.63K | ﹤0.01% | 488 |
|
|
2021
Q3 | $4K | Buy |
27
+1
| +4% | +$147 | ﹤0.01% | 628 |
|
|
2021
Q2 | $4K | Buy |
26
+22
| +550% | +$3.56K | ﹤0.01% | 552 |
|
|
2021
Q1 | $1K | Sell |
4
-121
| -97% | -$18.7K | ﹤0.01% | 447 |
|
|
2020
Q4 | $19K | Hold |
125
| – | – | ﹤0.01% | 217 |
|
|
2020
Q3 | $16K | Hold |
125
| – | – | ﹤0.01% | 202 |
|
|
2020
Q2 | $14K | Hold |
125
| – | – | ﹤0.01% | 215 |
|
|
2020
Q1 | $12K | Hold |
125
| – | – | ﹤0.01% | 210 |
|
|
2019
Q4 | $18K | Hold |
125
| – | – | ﹤0.01% | 212 |
|
|
2019
Q3 | $17K | Buy |
+125
| New | +$16.1K | ﹤0.01% | 210 |
|
|
2015
Q4 | – | Sell |
-82
| Closed | -$8K | – | 310 |
|
|
2015
Q3 | $8K | Hold |
82
| – | – | ﹤0.01% | 241 |
|
|
2015
Q2 | $9K | Hold |
82
| – | – | ﹤0.01% | 310 |
|
|
2015
Q1 | $9K | Buy |
82
+26
| +46% | +$2.97K | ﹤0.01% | 301 |
|
|
2014
Q4 | $6K | Buy |
+56
| New | +$5.9K | ﹤0.01% | 356 |
|
Other funds holding ZBH
MV Capital Management's ZBH Position: Q2 2026 in Review
MV Capital Management increased its Zimmer Biomet (ZBH) stake by 21% in Q2 2026, buying an estimated $263 and bringing the position to 17 shares worth $1.46K. The position accounts for ﹤0.01% of the portfolio, ranked #840.
MV Capital Management first reported a position in ZBH in Q4 2014 and has held it in 32 quarters since. The position peaked at $22.4K in Q1 2024. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- MV Capital Management held 17 shares of Zimmer Biomet worth $1.46K as of Q2 2026.
- MV Capital Management bought 3 Zimmer Biomet shares in Q2 2026, an estimated $263.
- Zimmer Biomet made up ﹤0.01% of MV Capital Management's portfolio in Q2 2026, its #840 holding.
- MV Capital Management first reported a position in Zimmer Biomet in Q4 2014 and has held it in 32 quarters since.
- MV Capital Management's Zimmer Biomet position peaked at $22.4K in Q1 2024.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on MV Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.